Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Board Meeting Intimation for BOARD MEETING HELD ON 9TH AUGUST 2022 FOR QTR. ENDED 30.06.22 UN AUDITED FINANCIAL STANDALONE AND CONSOLIDATED FINANCIAL RESULT AND OTHER .

LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 ,inter alia, to consider and approve board meeting on 9th August for folloWing agenda 1) To consider and approve un-audited financial results (standalone and consolidated) of the Company for the quarter ended on June 30, 2022; 2) To consider appointment of Mr. Anand A. Patel as an additional and Whole Time Director in the category of executive director (Promoter & Promoter Group) of the Company; 3) To consider appointment of M/s. Samir M. Shah & Associates, Chartered Accountants (Firm Reg. No. 122377W), Ahmedabad as the statutory auditors of the Company for a period of five years from the conclusion of 28th Annual General Meeting ('AGM') till the conclusion of the 33th AGM, in place of retiring auditors and recommended for final approval of the members at the ensuing AGM; 4) Any other business with the permission of the Chairman, if any.
28-07-2022
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

We wish to inform you that, Mr. Niren A. Desai (ICSI Membership Number - ACS 60285) has resigned from the post of Company Secretary & Compliance Officer of the Company with effect from closure of business hours on July 19, 2022.
20-07-2022
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

we hereby submit the confirmation certificate as received from M/s Link Intime India Private Limited, Registrar and Share transfer Agent for the Quarter Ended June 30, 2022.
08-07-2022
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Statement Of Investor Complaints For The Quarter Ended June 2022

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MAHENDRA G PATELDesignation :- Managing Director / Whole Time Director
08-07-2022
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel & PACs
15-06-2022
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanibhai Patel & PACs
15-06-2022
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanibhai Patel & PACs
10-06-2022
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel & PACs
10-06-2022
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanbhai Patel & PACs
07-06-2022
Bigul

LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel & PACs
03-06-2022
Next Page
Close

Let's Open Free Demat Account